GO TO NEWSROOMeast
dantelabs_marchio_positivo.png
Dante Labs announces appointments of Paul Jones, Simon Partridge and Christian Bourne to turbo-charge global population genomics programmes
May 11, 2021 01:00 ET | Dante Labs
CAMBRIDGE, United Kingdom, May 11, 2021 (GLOBE NEWSWIRE) -- Dante Labs today announced Paul Jones, Simon Partridge and Christian Bourne have joined the Company’s Executive Team as part of its...
INNATEvertnoir.png
Innate Pharma First Quarter 2021 Report
May 11, 2021 01:00 ET | INNATE PHARMA
Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signalCompany’s first NK cell engager selected by Sanofi as drug candidate...
INNATEvertnoir.png
Innate Pharma First Quarter 2021 Report
May 11, 2021 01:00 ET | INNATE PHARMA
Marseille, France, May 11, 2021 (GLOBE NEWSWIRE) -- Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signal Company’s...
INNATEvertnoir.png
Information Financiere du Premier Trimestre 2021
May 11, 2021 01:00 ET | INNATE PHARMA
Marseille, France, 11 mai 2021 (GLOBE NEWSWIRE) -- Progression de l’essai TELLOMAK : lacutamab a démontré un signal préliminaire positif permettant à la cohorte de patients présentant un mycosis...
Net asset value of EfTEN Real Estate Fund III AS as of 30.04.2021
May 11, 2021 01:00 ET | EfTEN Real Estate Fund III
The net asset value (NAV) of EfTEN Real Estate Fund III AS as of 30.04.2021 was 16.83 euros. The net asset value of the EPRA share (net book value excluding deferred income tax liability and fair...
imcd.jpg
IMCD N.V. publishes convocation for its upcoming Annual General Meeting
May 11, 2021 01:00 ET | IMCD N.V.
ROTTERDAM, The Netherlands (11 May 2021) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today published the convocation and agenda for its Annual...
Valneva Announces Closing of $107.6 million Global Offering
May 11, 2021 01:00 ET | VALNEVA
Saint-Herblain (France), May 11, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant...
Valneva annonce la réalisation de son Offre Globale de $107,6 millions
May 11, 2021 01:00 ET | VALNEVA
Saint-Herblain (France), le 11 mai 2021 – Valneva SE, société spécialisée dans le développement et la commercialisation de vaccins prophylactiques contre des maladies infectieuses générant...
LOGO.jpg
SOUTHEAST ASIA CAPITAL GROUP EXTENDS FULFILLMENT SCHEDULES FOR $2.9 BILLION TRANSACTIONS.
May 11, 2021 00:30 ET | Southeast Asia Capital Group, Inc
New York, NY, May 11, 2021 (GLOBE NEWSWIRE) -- Southeast Asia Capital Group, Inc., (“SEA Capital Group”) a Nevada corporation engaged in finance, international trade and project investments, today...
Attogene to expand SARS-CoV-2 variants testing in the United States
May 10, 2021 23:32 ET | Attogene
Austin, United States , May 10, 2021 (GLOBE NEWSWIRE) -- Attogene, a biotechnology company based in Austin, Texas, is expanding its product line to address the rapidly evolving SARS-CoV-2 testing...